Product details
Selank
Save $8.98 per unit with current offers
Explore Selank amounts, pricing, and product information.
Select your product
10mg · 1 unit · Total
$20.97 per unit
Save $8.98 total
WINTER30 −30%
Save your selection in the cart. Ordering is not open. Contact us for availability.
For laboratory research only. Not for human or veterinary use. Research-use policy.
Know your compound
Compound information
Selank
The Selank molecular reference is also indexed with the identifier TP-7.
Identity references 1 source
- Catalog identity
- SELANK
- Intended use
- Laboratory research
- Reference molecule
- Selank
- PubChem record
- CID 11765600
- Molecular formula
- C33H57N11O9
- Molecular weight
- 751.9 g/mol
Molecular data describe the reference compound in PubChem, not a laboratory analysis of this product or batch.
Primary literature
Verified research references
Primary-source bibliography for the named compound. These studies did not test this catalog item.
Randomized human research included
Selank2 verified references
Identity note
The cited literature names Selank as a study intervention; that name correspondence does not establish the identity, composition, formulation, quality, or equivalence of the PropeptIQ catalog material.
[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].
Zozulia AA · 2008 · Zh Nevrol Psikhiatr Im S S Korsakova
- Study design
- Randomized controlled trial
- Research context
- Human research
- Sample size
- 62 participants or samples
- Study population
- 62 patients with generalized anxiety disorder and neurasthenia; 30 in the Selank group and 32 in the medazepam comparison group.
PMID: 18454096
[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].
Medvedev VE · 2014 · Zh Nevrol Psikhiatr Im S S Korsakova
- Study design
- Human interventional study
- Research context
- Human research
- Sample size
- 60 participants or samples
- Study population
- 60 patients with phobic-anxiety and somatoform disorders; the indexed abstract does not specify allocation or blinding.
PMID: 25176261
Bibliographic references do not establish the identity, purity, safety, effectiveness, or suitability of this catalog item and are not use guidance. For legitimate laboratory and research use only; not for human or veterinary use.
Related catalog
